In AD, pieces of evidence revealed that SIRT-1 activation may be protective, while pharmacological inhibition aggravated tau accumulation [65] and abolished the resveratrol-mediated attenuation of autophagy in an AD cell model [66]. Here, MAPT is linked to Alzheimer disease.